Registro:

Referencias:

• Mei, Y.F., Wadell, G., Molecular determinants of adenovirus tropism (1995) Curr Top Microbiol Immunol, 199, pp. 213-228
• Kojaoghlanian, T., Flomenberg, P., Horwitz, M.S., The impact of adenovirus infection on the immunocompromised host (2003) Rev Med Virol, 13, pp. 155-171
• Kinchington, P.R., Romanowski, E.G., Gordon, Y.J., Prospects for adenovirus antivirals (2005) J Antimicrob Chemother, 55, pp. 424-429
• Esimone, C.O., Grunwald, T., Nworu, C.S., Kuate, S., Proksch, P., Überla, K., Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach (2009) Chemotherapy, 55, pp. 119-126
• Hoffman, J.A., Shah, A.J., Ross, L.A., Kapoor, N., Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation (2001) Biol Blood Marrow Transplant, 7, pp. 388-394
• Kaneko, H., Kato, K., Mori, S., Shigeta, S., Antiviral activity of NMSO3 against adenovirus in vitro (2001) Antiviral Res, 52, pp. 281-288
• Bordigoni, P., Carret, A.-S., Venard, V., Witz, F., Faou, A.L., Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation (2001) Clinical Infectious Diseases, 32 (9), pp. 1290-1297. , DOI 10.1086/319984
• La Rosa, A.M., Champlin, R.E., Mirza, N., Gajewski, J., Giralt, S., Rolston, K.V., Raad, I., Whimbey, E., Adenovirus infections in adult recipients of blood and marrow transplants (2001) Clinical Infectious Diseases, 32 (6), pp. 871-876. , DOI 10.1086/319352
• Legrand, F., Berrobi, D., Honbou, N., Freymuth, F., Faye, A., Davel, M., Mongenot, J.F., Vilmer, E., Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children (2001) Bone Marrow Transplant, 27, pp. 621-626
• Gavin, P.J., Katz, R.Z., Intravenous ribavirin treatment for severe adenovirus diseases in immunocompromised children (2002) Pedriatrics, 110, pp. 1-8
• Lankester, A., Heemkerk, C.B., Claas, E.C., Schilham, M.W., Beersma, M.F., Bredius, R.G., Van Tol, M.J., Kroes, A.C., Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection (2004) Clin Infect Dis, 38, pp. 1521-1525
• Robel, P., Bourreau, E., Corpechot, C., Dang, D.C., Halberg, F., Clarke, C.J., Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development (1987) Steroid Biochem, 27, pp. 649-655
• Dalla Valle, L., Couet, J., Labrie, Y., Simard, J., Belvedere, P., Simontacchi, C., Occurrence of cytochrome P450c17 mRNA and dehydroepiandrosterone biosynthesis in the rat gastrointestinal tract (1995) Mol Cell Endocrinol, 111, pp. 83-92
• Loria, R.M., Inge, T.H., Cook, S.S., Szakal, A.K., Regelson, W., Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA) (1988) J Med Virol, 26, pp. 301-314
• Van Vollenhoven, R., Dehydroepiandrosterone for the treatment of systemic lupus erythematosus (2002) Expert Opinion Pharmacother, 3, pp. 23-31
• Pedersen, N.C., North, T.W., Rigg, R., Reading, C., Higgins, J., Leutenegger, C., Henderson, G.L., Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: Initial enhancement leading to long-term suppression (2003) Vet Immunol Immunopathol, 94, pp. 133-148
• Mortola, J., Yen, S.J., The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women (1990) J Clin Endocrinal Metab, 71, pp. 696-704
• Lardy, H., Kneer, N., Wei, Y., Partridge, B., Marwah, P., Ergosteroids II: Biologically active metabolites and synthetic derivatives of dehydroepiandrosterone (1998) Steroids, 63, pp. 158-165
• Henderson, E., Yang, J., Schwartz, A., Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication (1992) AIDS Res Hum Retroviruses, 8, pp. 625-631
• Bradley, W., Kraus, L., Good, R., Day, N., Dehydroepiandrosterone inhibits replication of feline immunodeficiency virus in chronically infected cells (1995) Vet Immunol Immunopathol, 46, pp. 159-168
• Diallo, K., Loemba, H., Oliveira, M., Mavoungou, D.D., Wainberg, M.A., Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone (2000) Nucleosides Nucleotides Nucleic Acids, 19, pp. 2019-2024
• Mavoungou, D., Poaty-Mavoungou, V., Akoume, M., Ongali, B., Mavoungou, E., Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28) (2005) Virol J, 11, pp. 9-10
• Acosta, E.G., Bruttomesso, A.C., Bisceglia, J.A., Wachsman, M.B., Galagovsky, L.R., Castilla, V., Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro (2008) Virus Res, 135, pp. 203-212
• Romanutti, C., Bruttomesso, A.C., Bisceglia, J.A., Castilla, V., Galagovsky, L.R., Wachsman, M.B., In vitro antiviral activity of dehydroepiandrosterone and synthetic derivatives against vesicular stomatitis virus (2009) Vet J, 182, pp. 327-335
• Heftmann, E., Androgens (1970) Steroid Biochemistry, pp. 115-130. , London Academic Press
• Sondheimer, F., Burstein, S., Mechoulam, R., Syntheses in the cardiac aglycone field. III. The conversion of a 14- - To a 14--hydroxy group in the androstane series. The ultraviolet spectra of- 15-androsten-17-ones (1960) J Am Chem Soc, 82, pp. 3209-3212
• Defaye, G., Chambaz, E.M., Synthesis of 15- - Hydroxylated derivatives of dehydroisoandrosterone and isoandrosterone (1978) Tetrahedron Lett, 19, pp. 3849-3850
• Numazawa, M., Nagaoka, M., Stereospecific synthesis of 16--hydroxy-17-oxo steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17-ketones and its reaction mechanism (1982) J Org Chem, 47, pp. 4024-4029
• Numazawa, M., Osawa, Y., Improved synthesis of 16 alpha-hydroxylated androgens: Intermediates of estriol formation in pregnancy (1978) Steroids, 32, pp. 519-527
• Johnson, W.S., Gastambide, B., Pappo, R., The action of lead tetra-acetate on an enol acetate. Their interconversion and rearrangement (1957) J Am Chem Soc, 79, pp. 1991-1994
• Iwasaki, M., The Reformatsky reaction of 17-ketosteroids with ethyl--bromopropionate (1967) Steroids, 9, pp. 373-386
• Leeds, N.S., Fukushima, D.K., Gallager, T.F., Studies of steroid ring D epoxides of enol acetates: A new synthesis of estriol and of androstane-3- ,16- ,17--triol (1954) J Am Chem Soc, 76, pp. 2943-2948
• Bruttomesso, A.C., Gros, E.G., Ponce, M.A., Balsells, R.E., Photooxygenation of pregnanes (2004) Helv Chim Acta, 87, pp. 2987-3003
• Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival (1986) J Immunol Methods, 89, pp. 271-277
• Wachsman, M.B., López, E.M.F., Ramírez, J.A., Galagovsky, L.R., Coto, C.E., Antiviral effect of brassinosteroids against herpes virus and arenaviruses (2000) Antivir Chem Chemother, 11, pp. 71-77
• Talarico, L.B., Castilla, V., Rámirez, J.A., Galagovsky, L.R., Wachsman, M.B., Synergistic in vitro interactions between (22S,23S)-3--bromo-5- ,22,23-trihydroxystigmastan-6-one and foscarnet against herpes simples virus type 1 (2006) Chemotherapy, 52, pp. 38-42
• Loria, R.M., Padgett, D.A., Androstenediol regulates systemic resistance against lethal infections in mice (1992) Arch Virol, 127, pp. 103-115
• Padgett, D.A., Loria, R.M., Sheridan, J.F., Steroid hormone regulation of antiviral immunity (1997) J Neuroimmunol, 78, pp. 203-311
• Chang, C.C., Ou, Y.C., Rang, S.L., Chen, C.J., Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection (2005) J Gen Virol, 86, pp. 2513-2523
• Ashida, K., Goto, K., Zhao, Y., Okabe, T., Yanase, T., Takayanagi, R., Nomura, M., Nawata, H., Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase (2005) Biochim Biophys Acta, 1728, pp. 84-94
• Ziegler, C.G., Sicard, F., Sperber, S., Ehrhart-Bornstein, M., Bornstein, S.R., Krug, A.W., DHEA reduces NGF-mediated cell survival in serum-deprived PC12 cells (2006) Ann NY Acad Sci, 1073, pp. 306-311
• Schümann, M., Dobbelstein, M., Adenovirusinduced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny (2006) Cancer Res, 66, pp. 1282-1288

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------